Abbott cancer drug moves through accelerated process

06/6/2007 | ScientificAmerican.com

A new program to speed drug development moved an Abbott Laboratories cancer drug through the first round of human testing six months faster than usual. The drug was the first to be tested under the National Cancer Institute's Experimental Therapeutics program, which aims to cut up to a year off the usual 10- to 12-year drug clearance process.

View Full Article in:

ScientificAmerican.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT